Budesonide in the treatment of Crohn's disease: A meta-analysis

Alimentary Pharmacology and Therapeutics

Volumn 14, Issue 11, 2000, Pages 1419-1428

  Papi, C ^a   Luchetti, R ^a   Gili, L ^a   Montanti, S ^a   Koch, M ^a   Capurso, L ^a  

^a SAN FILIPPO NERI HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BUDESONIDE; CORTICOSTEROID; MESALAZINE; METHYLPREDNISOLONE; PREDNISOLONE;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROHN DISEASE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; META ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; RELAPSE; REMISSION; SCORING SYSTEM; SIDE EFFECT; STEROID THERAPY;

ADMINISTRATION, ORAL; ADMINISTRATION, TOPICAL; ANTI-INFLAMMATORY AGENTS; BUDESONIDE; CROHN DISEASE; DOUBLE-BLIND METHOD; GLUCOCORTICOIDS; HUMANS; RANDOMIZED CONTROLLED TRIALS;

EID: 0033710965     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2000.00867.x     Document Type: Article

References (38)

1. Overview of newer glucocorticosteroid preparations for inflammatory bowel disease
2. Old drugs with a new face: Corticosteroids
3. Canadian Inflammatory Bowel Disease Study Group. Oral budesonide for active Crohn's disease
4. A comparison-of budesonide with prednisolone for active Crohn's disease
5. German/Austrian Budesonide Study Group. Oral pH-modified release budesonide versus 6 methyl-prednisolone in active Crohn's disease
6. The Global Budesonide Study Group. Oral budesonide is as effective as oral prednisolone in active Crohn's disease
7. Budesonide versus prednisone in the treatment of active Crohn's disease
8. National Cooperative Crohn's Disease Study: Results of drug treatment
9. European Cooperative Crohn's Disease Study: Result of drug treatment
10. Clinical, biological and endoscopic picture of attacks of Crohn's disease. Evolution on prednisolone
11. Review article: The medical management of Crohn's disease
12. Medical therapy of inflammatory bowel disease
13. The German Budesonide Study Group. Treatment of active and postactive ileal and colonic Crohn's disease with oral pH-modified-release budesonide
14. The German Budesonide Study Group. Treatment of active Crohn's ileocolitis with oral pH-modified budesonide
15. Budesonide in glucocorticoid dependent chronic active Crohn's disease; a pilot study
16. Oral budesonide in active Crohn's disease
17. Treatment of active Crohn's disease with an oral slow-release budesonide formulation
18. Bone turnover during short term therapy with methylprednisolone or budesonide in Crohn's disease
19. A method for assessing the quality of a randomised control trial
20. A quality assessment of randomised control trials of primary treatment of breast cancer
21. Meta-analysis in clinical trials
22. An assessment of clinically useful measures of the consequences of treatment
23. Meta-analysis of clinical trials based on censored end-points: Simplified theory and implementation of the statistical algorithms on a microcomputer
24. Meta-analysis in clinical research
25. International Budesonide-Mesalamine Study Group. A comparison of budesonide and mesalamine for active Crohn's disease
26. Canadian Inflammatory Bowel Disease Study Group. Oral budesonide as maintenance treatment for Crohn's disease: A placebo-controlled, dose-ranging study
27. Budesonide prolongs time to relapse in ileal and ileocaecal Crohn's disease. A placebo controlled one year study
28. Global Budesonide Study Group. Oral budesonide as maintenance therapy in Crohn's disease-results of a 12-month study
29. The Budesonide Study Group. Low dose oral pH modified release budesonide for maintenance of steroid induced remission in Crohn's disease
30. Oral budesonide for prevention of postsurgical recurrence in Crohn's disease
31. Low dose Budesonide treatment for prevention of postoperative recurrence of Crohn's disease: A multicentre randomized placebo-controlled trial
32. Predictability of the postoperative course of Crohn's disease
33. Endoscopioc monitoring of Crohn's disease: A prospective randomized clinical trial
34. Frequency of glucocorticoid resistance and dependency in Crohn's Disease
35. Clinical pattern of corticosteroid dependent Crohn's disease
36. Glucocorticoids for inhalation
37. Switch from systemic steroids to budesonide controlled ileal release (CIR) capsules in steroid-dependent patients with Crohn's disease